Membrane permeation by multidrug-resistance-modulators and non-modulators: Effects of hydrophobicity and electric charge

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 3, 2000, Pages 289-296

  Castaing, Madeleine ^a   Brouant, Pierre ^a   Loiseau, Alain ^b   Santelli Rouvier, Christiane ^a   Santelli, Maurice ^a   Alibert Franco, Sandrine ^a   Mahamoud, Abdallah ^a   Barbe, Jacques ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ANTIPARASITIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALMODULIN INHIBITOR; CLOMIPRAMINE; DILTIAZEM; DIPYRIDAMOLE; LIPOSOME; MEPACRINE; PROPRANOLOL; QUININE; THIORIDAZINE; VERAPAMIL;

ARTICLE; BIOLOGICAL MODEL; CELL INTERACTION; ELECTRIC ACTIVITY; LIPOPHILICITY; MEMBRANE TRANSPORT; MULTIDRUG RESISTANCE; NONHUMAN; PHOSPHOLIPID MEMBRANE;

EID: 0034026078     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001773977     Document Type: Article

References (39)

1. Beck, W. T. (1987) The cell biology of multiple drug resistance. Biochem. Pharmacol. 36: 2879-2887
2. Bennis, S., Faure, P., Chapey, C., Hu, Y. P., Fourche, J., El Yamani, J., Robert, J. (1997) Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin. Anti-Cancer Drugs 8: 610-617
3. Betageri, G. V., Dipali, S. R. (1993) Partioning and thermodynamics of dipyridamole in the n-octanol/buffer and liposome systems. J. Pharm. Pharmacol. 45: 931-933
4. Bouzoubaa, M., Leclerc, G., Decker, N., Schwartz, J., Andermann, G. (1984) Synthesis and β-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers. J. Med. Chem. 27: 1291-1294
5. Callaghan, R., Riordan, J. R. (1995) Collateral sensitivity of multidrug resistant cells to narcotic analgesics is due to effects on the plasma membrane. Biochim. Biophys. Acta 1236: 155-162
6. Callaghan, R., Stafford, A., Epand, R. M. (1993) Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties. Biochim. Biophys. Acta 1175: 277-282
7. Cano-Gauci, D. F., Riordan, J. R. (1987) Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation. Biochem. Pharmacol. 36: 2115-2123
8. Castaing, M., Kraus, J. L., Ponge, C. (1991) Permeability of cryptands through dihexadecyl phosphate bilayer membranes. Biophys. Chem. 39: 17-29
9. Craig, P. N. (1990) Drug compendium. In: Drayton, C. J. (ed.) Comprehensive Medicinal Chemistry. Vol 6, Pergamon Press, Oxford, pp 237-991
10. Drori, S., Eytan, G. D., Assaraf, Y. G. (1995) Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur. J. Biochem. 228: 1020-1029
11. Ecker, G., Chiba, P., Hitzler, M., Schmid, D., Visser, K., Cordes, H. P., Csöllei, J., Seydel, J. K., Schaper, K. J. (1996) Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance. J. Med. Chem. 39: 4767-4774
12. Fersht, A. (1985) Practical Kinetics. In: Freeman, W. H. (ed.) Enzyme Structure and Mechanism. 2th edn, Freeman, W. H. and Company, New York, pp 176-192
13. Ford, J. M. (1995) Modulators of multidrug resistance. Preclinical studies. Hematol. Oncol. Clin. North Am. 9: 337-361
14. Ford, J. M. (1996) Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitizers. Eur. J. Cancer 32A: 991-1001
15. Ford, J. M., Hait, W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42: 155-199
16. Ford, J. M., Yang, J. M., Hait, W. N. (1996) P-glycoprotein-mediated multidrug resistance: experimental and clinical strategies for its reversal. Cancer Treat. Res. 87: 3-38
17. Hevér A., Santelli-Rouvier, C., Brouant, P., El Khyari, S., Molnar, J., Barra, Y., Barbe, J. (1998) Effect of new thioacridine derivatives on P-gp function and on mdrl gene expresion. Anticancer Res. 18: 3053-3058
18. Inaba, M., Maruyama, E. (1988) Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine. Cancer Res. 48: 2064-2067
19. Klohs, W. D., Steinkampf, R. W., Havlick, M. J., Jackson, R. C. (1986) Resistance to anthrapyrazoles and anthracyclines in multi-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. Cancer Res. 46: 4352-4356
20. Korolkovas, A. (1970a) Theories of drug action.In: John Wiley and Sons (eds) Essentials of Molecular Pharmacology, Background for Drug Design. Wiley-Interscience, New York, pp 265-288
21. Korolkovas, A. (1970b) Mechanism of Drug Action.In: John Wiley and Sons (eds) Essentials of Molecular Pharmacology, Background for Drug Design. Wiley-Interscience, New York, pp 289-320
22. Leibovici, J., Klein, O., Wollman, Y., Donin, N., Mahlin, T., Shinitzky, M. (1996) Cell membrane fluidity and adriamycin retention in a tumor progression model of AKR lymphoma. Biochim. Biophys. Acta 1281: 182-188
23. Loiseau, A., Leroy, C., Castaing, M. (1997) Potassium transport in opossum kidney cells: effects of Na-selective and K-selective ionizable cryptands, and of valinomycin, FCCP and nystatin. Biochim. Biophys. Acta 1330: 39-49
24. Menassa, P. E., Sandorfy, C. (1986) A study of the permeation of dihexadecyl phosphate vesicles by various anesthetics. Biophys. Chem. 25: 175-179
25. Pajeva, I. K., Wiese, M., Cordes, H. P., Seydel, J. K. (1996) Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability. J. Cancer Res. Clin. Oncol. 122: 27-40
26. Ramu, A., Spanier, R., Rahamimoff, H., Fuks, Z. (1984) Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells. Br. J. Cancer 50: 501-507
27. Romsicki, Y., Sharon, F. J. (1999) The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry 38: 6887-6896
28. Seydel, J. K. (1991) Nuclear magnetic resonance and differential scanning calorimetry as tools for studying drug-membrane interactions. Trends Pharmacol. Sci. 12: 368-371
29. Seydel, J. K., Velasco, M. A., Coats, E. A., Cordes, H. P., Kunz, B., Wiese, M. (1992) The importance of drug-membrane interaction in drug research and development. Quant. Struct.-Act. Relat. 11: 205-210
30. Seydel, J. K., Coats, E. A., Cordes, H. P., Wiese, M. (1994) Drug membrane interaction and the importance for drug transport, distribution, accumulation, efficacy and resistance. Arch. Pharm. (Weinheim) 327: 601-610
31. Sikkema, J., de Bont, J. A. M., Poolman, B. (1994) Interaction of cyclic hydrocarbons with biological membranes. J. Biol. Chem. 269: 8022-8028
32. Szoka, F., Papahadjopoulos, D. (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reversed-phase evaporation. Proc. Natl. Acad. Sci. USA 75: 4194-4198
33. Taylor, P. J. (1990) Hydrophobic properties of drugs. In: Ramsden, C. A. (ed.) Comprehensive Medicinal Chemistry. Vol 4, Pergamon Press, Oxford, pp 241-294
34. Tocanne, J. F., Teissié, J. (1990) Ionization of phospholipids and phospholipid-supported interfacial lateral diffusion of protons in membrane model systems. Biochem. Biophys. Acta 1031: 111-142
35. Tsuruo, T. (1983) Reversal of acquired resistance to Vinca alkaloids and anthracycline antiobiotics. Cancer Treat. Rep. 67: 889-894
36. Tsuruo, T., Iida, H., Tsukagoshi, S., Sakurai, Y. (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41: 1967-1972
37. Webb, M. S. Wheeler J. J., Bally, M. B., Mayer L. D. (1995) The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery. Biochim. Biophys. Acta 1238: 147-155
38. Wiese, M., Pajeva, I. K. (1997) Molecular modeling study of the multidrug resistance modifiers cis- and trans-flupentixol. Pharmazie 52: 679-685
39. Zamora, J. M., Pearce, H. L., Beck, W. T. (1988) Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 33: 454-462